Recent Activity

Activity stream for all registered members at Stocks Talk.

  1. Vidhi Khanna posted a new thread.

    LTIM is in a unique position. Buy for TP ₹6200 (+20%)

    LTIM is in a unique position. It is trading below expensive high-growth tier-2 Indian IT cos & above the relatively inexpensive...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 18, 2025 at 8:24 PM
  2. Vidhi Khanna posted a new thread.

    Buy Cera Sanitaryware for Target Price ₹8500 (31% upside)

    Cera is leveraging premiumisation trends in India’s bathware segment. Targeting ₹2700 Cr in revenue by FY27, Co is investing in...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 17, 2025 at 7:43 PM
  3. Vidhi Khanna posted a new thread.

    Vishal Mega Mart is a play on rising aspirations in Tier 2+ India. TP ₹165 (+20%)

    Vishal Mega Mart is a play on rising aspirations in Tier 2+ India. It is a one-of-a-kind retailer catering to the ~₹70t opportunity &...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 16, 2025 at 8:07 PM
  4. Vidhi Khanna posted a new thread.

    Kalyan Jewellers has large growth opportunity from the huge unorganised market.

    Kalyan Jewellers has large growth opportunity from the huge unorganised market. Stock is trading at a discount of 10-40% despite having...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 15, 2025 at 8:47 PM
  5. Vidhi Khanna posted a new thread.

    Buy Laxmi Dental for Target Price ₹540 (26%)

    Laxmi Dental is India’s only fully integrated provider of dental solutions. It has an extensive B2B2C network. Business encompasses...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 14, 2025 at 7:59 PM
  6. Vidhi Khanna posted a new thread.

    TCS trades at 4% discount to average 10-year historical valuation. Compelling valuation

    TCS trades at 4% discount to average 10-year historical valuation. It has consistently gained market share across tech shifts over...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 13, 2025 at 8:31 PM
  7. Vidhi Khanna posted a new thread.

    Abbott India is immune from US tariff woes. Buy for TP ₹40128 (+16%)

    Abbott India is immune from US tariff woes. Its core portfolio productivity is highest in industry & will be able to report highest-ever...

    Forum: Latest Brokerage Stock Buy-Sell Reports

    Jul 12, 2025
Loading...